Wilate (antihemophilic factor, human/von Willebrand factor,human)
Last reviewed · Source: First Databank (FDB) drug data
Overview
USES: This product contains human factor VIII (also called antihemophilic factor) and von Willebrand factor complex. Factors are proteins normally found in the blood that help the blood to thicken (clot) and stop any bleeding. People with low levels of factor VIII and von Willebrand factor are at risk for bleeding longer after an injury/surgery and for bleeding inside the body (especially into the joints and muscles).
This product is used to temporarily replace the missing factors and reduce bleeding. Different brands of this product have different amounts of these factors, and so have different uses. These products are not interchangeable.
Do not change brands of this medication without the approval of your doctor. Some products are used to control and prevent bleeding episodes in people with low levels of factor VIII (hemophilia A). Some products are used to control and prevent bleeding episodes in people with low levels of von Willebrand factor (von Willebrand disease).
Some products are used to prevent excessive bleeding during and after surgery in patients with von Willebrand disease.
Generic name: antihemophilic factor, human/von Willebrand factor,human
Pronunciation: (FAK-tor VIII/von-WIL-e-brand FAK-tor)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Wilate
Indications
The following indications are listed for Wilate:
- Acquired Factor Viii Deficiency Disease
- Bleeding Episode In Acquired Factor Viii Deficiency Disease
- Bleeding Episode In Hemophilia A
- Bleeding Prevention In Von Willebrand Disease Type 3
- Hemophilia A
- Prevention Of Surgery-Induced Bleed In Von Willebrand's Disease
- Von Willebrand's Disease
Also known as: Angiohemophilia, Bleeding Prophylaxis In Type 3 Von Willebrand Disease, Congenital Factor Viii Deficiency Disease, Constitutional Thrombopathy, Hemorrhaging In Hemophilia A, Pseudohemophilia, Vascular Hemophilia, Von Willebrand Disease, Willebrand-Juergens Disease.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.